Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	72.71B
Revenue (ttm)	42.62B
Net Income (ttm)	3.63B
Shares Out	1.75B
EPS (ttm)	2.07
PE Ratio	20.12
Forward PE	20.41
Dividend	0.93 (2.24%)
Ex-Dividend Date	Sep 18, 2025

Volume	9,719,241
Average Volume	11,550,324
Open	41.10
Previous Close	40.95
Day's Range	40.86 - 41.60
52-Week Range	30.95 - 47.36
Beta	0.40
RSI	43.16
Earnings Date	Oct 24, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 18,265
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.